Intrinsic efficacy profiles of novel compounds with functional selectivity for GABAA receptor subtypes. Intrinsic efficacy values were determined in human recombinant GABAA receptors containing β3 and γ2 subunits, combined with α1, α2, α3, or α5 subunits, using whole-cell patch-clamp electrophysiology. Values are expressed relative to the efficacy measured at each subtype using the nonselective high efficacy benzodiazepine agonist chlordiazepoxide. Graphs are adapted from (Atack 2010, 2011).